drugset / Trial / NCT05108740

MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer

NCT05108740

Expanded access No longer available Novartis Pharmaceuticals

Summary

The purpose of this Managed Access Program (MAP) Cohort Treatment Plan is to provide guidance to the Physician for the treatment and monitoring of patients in the Cohort MAP.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule 10 mg Oral